Skip to search formSkip to main contentSkip to account menu

doxorubicin/mitomycin/vinblastine protocol

Known as: AVM protocol, MVA, DOX/MITO/VBL 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsMitomycinVinblastine
DoxorubicinDoxorubicin Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
Abstract Coronary microvascular networks play the key role in determining blood flow distribution in the heart. Matching local… 
Review
2014
Review
2014
Management of hepatic encephalopathy in the hospital.
Highly Cited
2012
Highly Cited
2012
Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E. coli
The depleting petroleum reserve, increasingly severe energy crisis, and global climate change are reigniting enthusiasm for… 
Highly Cited
2012
Highly Cited
2012
Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
BACKGROUND AND PURPOSE: Quantifying MVA rather than MVD provides better correlation with survival in HGG. This is attributed to a… 
Highly Cited
2010
Highly Cited
2010
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
Background We conducted a Phase I randomized, dose-escalation, route-comparison trial of MVA-CMDR, a candidate HIV-1 vaccine… 
Highly Cited
2009
Highly Cited
2009
Analysis and Simulation of a 6 kV, 6 MVA Modular Multilevel Converter
This paper describes the principle of operation of the Modular Multilevel Converter (M2C) and presents a new PWM scheme which can… 
Highly Cited
2007
Highly Cited
2007
Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC
ABSTRACT Although recombinants based on the attenuated poxvirus vectors MVA and NYVAC are currently in clinical trials, the… 
Highly Cited
2006
Highly Cited
2006
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
Human papillomavirus (HPV) is the etiologic agent for cervical cancer. In Mexico, a women dies every 2 h, and since 1990 the… 
Highly Cited
2004
Highly Cited
2004
Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Human papillomavirus (HPV) infection is associated with cervical cancer. Papillomaviruses can induce diseases ranging from warts… 
Highly Cited
2002
Highly Cited
2002
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Rhesus macaques were immunized with a replication-deficient vaccinia virus (MVA) expressing human immunodeficiency virus type 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)